JP2024543204A5 - - Google Patents
Info
- Publication number
- JP2024543204A5 JP2024543204A5 JP2024532708A JP2024532708A JP2024543204A5 JP 2024543204 A5 JP2024543204 A5 JP 2024543204A5 JP 2024532708 A JP2024532708 A JP 2024532708A JP 2024532708 A JP2024532708 A JP 2024532708A JP 2024543204 A5 JP2024543204 A5 JP 2024543204A5
- Authority
- JP
- Japan
- Prior art keywords
- glu
- crosslink
- aminomethyl
- trp
- ala
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21211815.2 | 2021-12-01 | ||
| EP21211815 | 2021-12-01 | ||
| PCT/EP2022/084077 WO2023099669A1 (en) | 2021-12-01 | 2022-12-01 | Peptide inhibitors of interleukin-23 receptor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024543204A JP2024543204A (ja) | 2024-11-19 |
| JP2024543204A5 true JP2024543204A5 (https=) | 2025-12-05 |
Family
ID=78821013
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024532708A Pending JP2024543204A (ja) | 2021-12-01 | 2022-12-01 | インターロイキン－２３受容体のペプチド阻害剤 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20250154198A1 (https=) |
| EP (1) | EP4440592A1 (https=) |
| JP (1) | JP2024543204A (https=) |
| KR (1) | KR20240111800A (https=) |
| CN (1) | CN118354781A (https=) |
| AU (1) | AU2022402440A1 (https=) |
| CA (1) | CA3240982A1 (https=) |
| CL (1) | CL2024001598A1 (https=) |
| IL (1) | IL313185A (https=) |
| MX (1) | MX2024006556A (https=) |
| TW (1) | TW202332682A (https=) |
| WO (1) | WO2023099669A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4471048A1 (en) | 2023-06-01 | 2024-12-04 | Zealand Pharma A/S | Peptide inhibitors of interleukin-23 receptor |
| EP4471049A1 (en) * | 2023-06-01 | 2024-12-04 | Zealand Pharma A/S | Peptide inhibitors of interleukin-23 receptor |
| CN121794283A (zh) * | 2023-09-08 | 2026-04-03 | 赛诺菲 | 作为选择性il-23受体抑制剂的新型肽 |
| WO2026013260A1 (en) | 2024-07-12 | 2026-01-15 | Zealand Pharma A/S | Peptide inhibitors of interleukin-23 receptor |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU723268B2 (en) | 1996-09-09 | 2000-08-24 | Zealand Pharma A/S | Improved solid-phase peptide synthesis and agent for use in such synthesis |
| US8946150B2 (en) | 2011-06-14 | 2015-02-03 | Medical Diagnostic Laboratories, LLC. | Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof |
| CN107206254B (zh) | 2014-07-17 | 2021-08-24 | 领导医疗有限公司 | 白细胞介素-23受体的口服肽抑制剂以及其治疗炎症性肠病的用途 |
| MX384213B (es) | 2015-07-15 | 2025-03-14 | Protagonist Therapeutics Inc | Inhibidores peptidicos del receptor de interleucina 23 y su uso para tratar enfermedades inflamatorias. |
| WO2018022937A1 (en) | 2016-07-27 | 2018-02-01 | Protagonist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 and their use to treat inflammatory diseases |
| WO2018089693A2 (en) | 2016-11-09 | 2018-05-17 | Protagonist Therapeutics, Inc. | Methods for determining and monitoring gastrointestinal inflammation |
| WO2018136646A1 (en) | 2017-01-18 | 2018-07-26 | Protagonist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| WO2020014646A1 (en) | 2018-07-12 | 2020-01-16 | Protagonist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| WO2021007433A1 (en) | 2019-07-10 | 2021-01-14 | Protagonist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| AU2021209086A1 (en) * | 2020-01-15 | 2022-08-04 | Janssen Biotech, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| CA3167751A1 (en) | 2020-01-15 | 2021-07-22 | Janssen Biotech, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| WO2021146458A1 (en) | 2020-01-15 | 2021-07-22 | Protagonist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
-
2022
- 2022-12-01 AU AU2022402440A patent/AU2022402440A1/en active Pending
- 2022-12-01 EP EP22830694.0A patent/EP4440592A1/en active Pending
- 2022-12-01 IL IL313185A patent/IL313185A/en unknown
- 2022-12-01 JP JP2024532708A patent/JP2024543204A/ja active Pending
- 2022-12-01 US US18/715,410 patent/US20250154198A1/en active Pending
- 2022-12-01 CA CA3240982A patent/CA3240982A1/en active Pending
- 2022-12-01 WO PCT/EP2022/084077 patent/WO2023099669A1/en not_active Ceased
- 2022-12-01 KR KR1020247021622A patent/KR20240111800A/ko active Pending
- 2022-12-01 MX MX2024006556A patent/MX2024006556A/es unknown
- 2022-12-01 CN CN202280079717.2A patent/CN118354781A/zh active Pending
- 2022-12-01 TW TW111146213A patent/TW202332682A/zh unknown
-
2024
- 2024-05-28 CL CL2024001598A patent/CL2024001598A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024543204A5 (https=) | ||
| JP2025134806A (ja) | インターロイキン２３受容体のペプチド阻害剤及び炎症性疾患を治療するためのその使用 | |
| ES2977537T3 (es) | Inhibidores peptídicos orales del receptor de interleucina-23 y su uso para tratar enfermedades inflamatorias intestinales | |
| JP5364583B2 (ja) | 合成ペプチドアミドおよびその二量体 | |
| ES2544573T3 (es) | Inhibidores diméricos de afinidad elevada de PSD-95 y su uso para el tratamiento del daño cerebral isquémico y del dolor | |
| DE69133354T2 (de) | Interleukin 1-beta protease und ihre inhibitoren | |
| CA3226492A1 (en) | Bicyclic peptide inhibitors of interleukin-23 receptor | |
| JPH10511086A (ja) | 改善された環状ｃｒｆ作用薬 | |
| CN108929375A (zh) | 拟肽大环化合物 | |
| ES2299253T3 (es) | Peptidos basados en la secuencia de la lactoferrina humana y sus usos,. | |
| IE921689A1 (en) | Terminally modified tri-, tetra- and pentapeptide¹anaphylatoxin receptor ligands | |
| KR19990077344A (ko) | 합성 il-10 동족체 | |
| KR20240111800A (ko) | 인터루킨-23 수용체의 펩티드 억제제 | |
| WO2020230780A1 (ja) | Ｒａｓ阻害ペプチド | |
| JPH08503217A (ja) | 血小板糖タンパク質▲ＩＩ▼ｂ／▲ＩＩＩ▼ａの阻害剤として有用な複素環式環により結合された環状化合物 | |
| CA2095360A1 (en) | Modified hexa- and heptapeptide anaphylatoxin receptor ligands | |
| JPH0676437B2 (ja) | Ｇｒｆ類似体 | |
| JP2949129B2 (ja) | 胃腸運動刺激活性を有するモチリン類似ポリペプチド | |
| JP7698318B2 (ja) | Ｖｉｐｒ２アンタゴニストペプチド | |
| JPS62123198A (ja) | デカペプチド | |
| JP2001518515A (ja) | リウマチ性関節炎の治療組成物および治療方法 | |
| JP2003501443A (ja) | ニューロメジンｂおよびソマトスタチンレセプターアゴニスト | |
| JP2017512799A (ja) | 環状プロサポシンペプチドおよびその使用 | |
| JP2003500334A (ja) | 抗ｈｉｖ作用を有するｒａｎｔｅｓ由来ペプチド | |
| JP7032808B2 (ja) | ペプチドもしくはその薬学的に許容される塩、またはそれらのプロドラッグ |